epa08814068 An undated handout picture made available by the German pharmaceutical company Biontec shows the dosing of BNT162b2, the mRNA-based vaccine candidate against COVID-19, during the clinical test. Pfizer and Biontech SE announced on 11 November 2020 that they have reached an agreement with the European Commission to supply 200 million doses of their investigational BNT162b2 mRNA-based vaccine candidate against COVID-19 to European Union (EU) Member States, with an option for the European Commission to request an additional 100 million doses. EPA/BIONTECH SE / HANDOUT HANDOUT EDITORIAL USE ONLY/NO SALES
I dati delle vaccinazioni evidenziano che in Campania sono state 9 milioni le dosi somministrate.
4.352.380 le prime dosi somministrate, 3.875.389 le seconde dosi mentre sono 749.851 le persone che hanno ricevuto anche la terza dose.